Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor–Positive Breast Cancer

Hormone receptor–positive (HR+) disease is the most frequently diagnosed subtype of breast cancer. Among tumor subtypes, natural course of HR+ breast cancer is indolent with favorable prognosis compared to other subtypes such as human epidermal growth factor protein 2–positive disease and triple-neg...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eunice Yoojin, Lee, Dae-Won, Lee, Kyung-Hun, Im, Seock-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582540/
https://www.ncbi.nlm.nih.gov/pubmed/37817306
http://dx.doi.org/10.4143/crt.2023.846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582540/
https://www.ncbi.nlm.nih.gov/pubmed/37817306
http://dx.doi.org/10.4143/crt.2023.846

Ejemplares similares